These are consistent with our data, which show a reduction in TNF-α and IL-6 against LPS and IL-6, IL-8, MCP-1, and RANTES in response to Mtb infection in T2DM individuals who were being treated with metformin. The gene discussed is CCL2; the disease is type 2 diabetes mellitus.